Current status of proximal gastrectomy for gastric and esophagogastric junctional cancer: A review.

gastric cancer proximal gastrectomy reconstruction method

Journal

Annals of gastroenterological surgery
ISSN: 2475-0328
Titre abrégé: Ann Gastroenterol Surg
Pays: Japan
ID NLM: 101718062

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 01 04 2020
revised: 09 05 2020
accepted: 23 05 2020
entrez: 2 10 2020
pubmed: 3 10 2020
medline: 3 10 2020
Statut: epublish

Résumé

Proximal gastrectomy (PG) is one of the function-preserving surgical methods for the treatment of upper gastric cancer. Favorable postoperative results have been reported in comparison with total gastrectomy. However, because there are challenges, such as postoperative reflux esophagitis, anastomotic stenosis, and residual food, appropriate selection of a reconstruction method is crucial. Some methods include esophagogastric anastomosis, including simple esophagogastrostomy, tube-like stomach esophagogastrostomy, side overlap with fundoplication by Yamashita, and double-flap technique, and reconstruction using the small intestine, including double-tract methods, jejunal interposition, and jejunal pouch interposition. However, standard reconstruction methods are yet to be established. PG has also been employed in early gastric cancer of the upper third of the stomach, and indications have also been extended to esophagogastric junction cancer, which has shown an increase in recent years. Although many retrospective studies have revealed the functional benefits or oncological safety of PG, the characteristics of each surgical procedure should be understood so that an appropriate reconstruction method, with a reflux prevention mechanism and minimal postoperative injury, can be selected.

Identifiants

pubmed: 33005844
doi: 10.1002/ags3.12365
pii: AGS312365
pmc: PMC7511558
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

498-504

Informations de copyright

© 2020 The Authors. Annals of Gastroenterological Surgery published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Gastroenterological Surgery.

Déclaration de conflit d'intérêts

Conflict of interests: There are no conflicts of interest to disclose. Author Contributions: (I) conception and design: S Nunobe; (II) administrative support: S Nunobe; (III) provision of study materials or patients: all authors; (IV) collection and assembly of data: S Nunobe; (V) data analysis and interpretation: S Nunobe; (VI) manuscript writing: all authors; (VII) final approval of manuscript: all authors.

Références

Dig Dis Sci. 2012 Mar;57(3):738-45
pubmed: 21953142
Gastric Cancer. 2019 Sep;22(5):999-1008
pubmed: 30788750
Cancer Lett. 2008 Sep 28;269(1):18-25
pubmed: 18501504
Ann Surg Oncol. 2015 Mar;22(3):772-9
pubmed: 25212836
Gastric Cancer. 2019 Sep;22(5):1029-1035
pubmed: 30778799
Ann Surg. 1996 Jun;223(6):701-6; discussion 706-8
pubmed: 8645043
Langenbecks Arch Surg. 2012 Jan;397(1):57-62
pubmed: 21853418
Gastric Cancer. 2020 Feb 14;:
pubmed: 32060757
World J Gastroenterol. 2016 Jul 14;22(26):5888-95
pubmed: 27468183
World J Surg. 2005 Dec;29(12):1592-9
pubmed: 16311849
Hepatogastroenterology. 2012 Oct;59(119):2032-6
pubmed: 22687965
Surg Today. 1999;29(4):389-91
pubmed: 10211578
Surg Endosc. 2013 Jan;27(1):146-53
pubmed: 22736285
Eur J Gastroenterol Hepatol. 2002 Feb;14(2):107-13
pubmed: 11981333
Surgery. 2014 Jul;156(1):57-63
pubmed: 24799083
World J Surg. 2013 Mar;37(3):558-64
pubmed: 23254949
Surg Laparosc Endosc. 1995 Dec;5(6):487-91
pubmed: 8612000
World J Surg. 2016 Oct;40(10):2419-24
pubmed: 27094564
Gastric Cancer. 2019 Sep;22(5):1060-1068
pubmed: 30830641
Gastric Cancer. 2019 Sep;22(5):1036-1043
pubmed: 30838469
Am J Surg. 2008 Oct;196(4):587-91
pubmed: 18519129
Langenbecks Arch Surg. 2014 Apr;399(4):517-23
pubmed: 24424495
Dig Surg. 2010;27(6):502-8
pubmed: 21079403
Gastric Cancer. 2009;12(2):88-94
pubmed: 19562462
Br J Surg. 2006 Aug;93(8):975-80
pubmed: 16739101
Gastric Cancer. 2011 Oct;14(4):301-16
pubmed: 21894577
J Gastrointest Surg. 2014 Mar;18(3):497-504
pubmed: 24163139
Ann Surg Oncol. 2013 Aug;20(8):2683-92
pubmed: 23504120
Br J Surg. 2011 Feb;98(2):255-60
pubmed: 21082693
BJS Open. 2020 Apr;4(2):252-259
pubmed: 32207570
Gut. 1998 Sep;43(3):342-4
pubmed: 9863478
Br J Surg. 2003 Jul;90(7):850-3
pubmed: 12854112
Hepatogastroenterology. 2007 Jul-Aug;54(77):1604-8
pubmed: 17708311
Gastric Cancer. 2015 Apr;18(2):407-16
pubmed: 24801198
Langenbecks Arch Surg. 2019 Feb;404(1):81-91
pubmed: 30612151
Gastric Cancer. 2014;17(3):562-70
pubmed: 24052482
Gastric Cancer. 2018 Jan;21(1):68-73
pubmed: 28194522
Anticancer Res. 2014 Aug;34(8):4293-8
pubmed: 25075061
Hepatogastroenterology. 2006 Mar-Apr;53(68):301-3
pubmed: 16608044
J Am Coll Surg. 2009 Sep;209(3):344-51
pubmed: 19717038
Ann Surg Oncol. 2017 Jun;24(6):1635-1642
pubmed: 28130623
Br J Surg. 2010 Apr;97(4):558-62
pubmed: 20169569
Ann Surg. 2019 Aug 8;:
pubmed: 31404008
World J Surg. 2014 May;38(5):1100-6
pubmed: 24310733
Hepatogastroenterology. 2007 Jan-Feb;54(73):304-7
pubmed: 17419280
Gastric Cancer. 2013 Jul;16(3):282-9
pubmed: 22821182
Ann Surg. 1955 Sep;142(3):486-506
pubmed: 13249345
Gastric Cancer. 2019 Jan;22(1):123-129
pubmed: 29357013
Gastric Cancer. 1999 May;2(1):40-45
pubmed: 11957069
Gastric Cancer. 2017 Jul;20(4):728-735
pubmed: 27942874
J Am Coll Surg. 2016 Aug;223(2):e7-e13
pubmed: 27157920
Hepatogastroenterology. 2013 May;60(123):616-9
pubmed: 23108089
World J Surg. 2008 Jul;32(7):1473-7
pubmed: 18264827
Oncol Rep. 2001 Nov-Dec;8(6):1293-9
pubmed: 11605052
Gastric Cancer. 2011 Aug;14(3):279-84
pubmed: 21519869
Am J Surg. 2012 Aug;204(2):203-9
pubmed: 22813641
Am J Surg. 1997 Apr;173(4):292-7
pubmed: 9136783

Auteurs

Souya Nunobe (S)

Department of Gastroenterological surgery Cancer Institute Ariake Hospital Tokyo Japan.

Satoshi Ida (S)

Department of Gastroenterological surgery Cancer Institute Ariake Hospital Tokyo Japan.

Classifications MeSH